RFK Jr. Defies Health Establishment, Axes $500 Million in mRNA Vaccine Funding

What Happened

Health and Human Services Secretary Robert F. Kennedy Jr. has canceled nearly $500 million in federal funding for 22 mRNA vaccine development projects.

These contracts, which were originally authorized through the Biomedical Advanced Research and Development Authority (BARDA), focused on vaccines for respiratory illnesses like COVID-19 and influenza.

The decision drew immediate fire from public health officials, pharmaceutical leaders, and global vaccine advocates. Critics claim the cut will weaken America’s ability to respond to future pandemics and endanger vaccine programs overseas.

Kennedy defended the move, calling it a necessary realignment of priorities. He has long questioned the pharmaceutical industry’s influence over federal health agencies. He has openly criticized the rush and rollout of mRNA technology during the COVID era.

Why It Matters

During the pandemic, Americans watched as emergency powers expanded, vaccine mandates rolled out, and Big Pharma reaped record profits. This cut in funding indicates that the days of blank checks for experimental platforms may be coming to an end.

While public health officials and legacy media outlets may view this as a reckless move, to many Americans, especially those skeptical of government overreach, it reads as a much-needed correction.

One of Today’s Fastest Growing Company Might Surprise You

Meet $MODE, the disruptor turning phones into income generators.*

Elon Musk said that “universal income will be necessary if AI takes over most human jobs,” and Mode is pioneering privatized UBI powered by technology. Their 3-year 32,481% revenue growth ranked them the #1 software company on Deloitte’s fastest-growing companies list in 2023.

⏰ Pre-IPO almost sold out — invest now at $0.30/share now.

Some global health officials have warned of the potential consequences for vaccine access in low-income countries. But none of these critics have addressed the underlying concern of whether the funding was being spent wisely, transparently, or with proper oversight.

RFK Jr. is remaining staunch in his crusade against Big Pharma. In doing so, he has revealed how deeply entrenched the mRNA vaccine lobby has become in federal health policy.

How It Affects Americans

A major cut in funding such as this shows there has been a notable transformation in how health decisions are being made in Washington. Under Kennedy’s leadership, the Department of Health and Human Services is pulling away from a top-down, pharma-driven model and moving toward something leaner and more accountable.

If future pandemic funding focuses on proven technologies rather than the latest biotech trend, that could mean fewer costly experiments and more rigorous safety standards. It could also mean less pressure from government agencies to comply with blanket vaccination strategies, especially for diseases with low fatality rates among healthy adults.

On the other hand, canceling funding for mRNA research could delay future vaccine options. While Americans' opinions on mRNA vaccines and vaccines in general seem mixed and unsure, millions of Americans who felt bulldozed during the pandemic and forced to comply or lose their jobs may feel like this is a long-overdue rebalancing of power.

The fight over vaccines is shifting more toward public trust in institutions, freedom, and whether Americans have any real say in the direction of national health policy.

*Mode Mobile recently received their ticker reservation with Nasdaq ($MODE), indicating an intent to IPO in the next 24 months. An intent to IPO is no guarantee that an actual IPO will occur.

The Deloitte rankings are based on submitted applications and public company database research, with winners selected based on their fiscal-year revenue growth percentage over a three-year period.

Please read the offering circular and related risks at invest.modemobile.com.